Literature DB >> 21305470

Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells.

Alessandro Prigione1, James Adjaye.   

Abstract

Reprogramming somatic cells to induced pluripotent stem (iPS) cells transforms differentiated cells to an embryonic stem (ES) cell-like state characterized by the acquisition of pluripotency and self-renewal capabilities. We recently demonstrated that human ES and iPS cells share similar mitochondrial properties and bioenergetic metabolism, which are distinct from those of fibroblasts. In the present study, we have applied a global transcriptome profiling approach to compare the mitochondrial-related transcriptional signature upon the loss of self renewal and pluripotency in human ES and iPS cells. This was achieved by inducing in vitro and in vivo spontaneous differentiation. ES and iPS cells showed a similar degree of correlation both in the undifferentiated state and in all the stages of differentiation analyzed, suggesting that their transcriptional similarities are retained upon differentiation. Moreover, comparable induction of transcripts involved in epithelial to mesenchymal transition was observed in both cell types. Analysis of mitochondrial-related nuclear transcripts revealed consensual regulation of genes involved in mitochondrial biogenesis and bioenergetic metabolism upon in vitro differentiation of human ES and iPS cells, while specific differences were identified within in vivo differentiated cells. Significant changes were not detected for antioxidant-related genes. Finally, we formulate a "metabolic state hypothesis" linking mitochondrial state and cellular metabolism to the stage of differentiation. Overall, our data unveil differences and similarities between human ES and iPS cells during spontaneous differentiation and suggest that the study of mitochondrial and metabolic remodeling may reveal key mechanisms underlying the acquisition, maintenance and exit of a self-renewing pluripotent state.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21305470     DOI: 10.1387/ijdb.103198ap

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  56 in total

1.  Metabolome and metaboproteome remodeling in nuclear reprogramming.

Authors:  Clifford Dl Folmes; D Kent Arrell; Jelena Zlatkovic-Lindor; Almudena Martinez-Fernandez; Carmen Perez-Terzic; Timothy J Nelson; Andre Terzic
Journal:  Cell Cycle       Date:  2013-07-08       Impact factor: 4.534

2.  Hypoxia-inducible factors have distinct and stage-specific roles during reprogramming of human cells to pluripotency.

Authors:  Julie Mathieu; Wenyu Zhou; Yalan Xing; Henrik Sperber; Amy Ferreccio; Zsuzsa Agoston; Kavitha T Kuppusamy; Randall T Moon; Hannele Ruohola-Baker
Journal:  Cell Stem Cell       Date:  2014-03-20       Impact factor: 24.633

Review 3.  Glucose metabolism, hyperosmotic stress, and reprogramming of somatic cells.

Authors:  Rosalinda Madonna; Aniko Görbe; Peter Ferdinandy; Raffaele De Caterina
Journal:  Mol Biotechnol       Date:  2013-10       Impact factor: 2.695

Review 4.  Metabolic restructuring and cell fate conversion.

Authors:  Alessandro Prigione; María Victoria Ruiz-Pérez; Raul Bukowiecki; James Adjaye
Journal:  Cell Mol Life Sci       Date:  2015-01-14       Impact factor: 9.261

5.  Mitochondrial dynamics regulate growth cone motility, guidance, and neurite growth rate in perinatal retinal ganglion cells in vitro.

Authors:  Michael B Steketee; Stavros N Moysidis; Jessica E Weinstein; Alex Kreymerman; Jose P Silva; Siraj Iqbal; Jeffrey L Goldberg
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-30       Impact factor: 4.799

6.  Ovarian tumor-initiating cells display a flexible metabolism.

Authors:  Angela S Anderson; Paul C Roberts; Madlyn I Frisard; Matthew W Hulver; Eva M Schmelz
Journal:  Exp Cell Res       Date:  2014-08-27       Impact factor: 3.905

7.  Mitochondrial metabolism directs stemness and differentiation in P19 embryonal carcinoma stem cells.

Authors:  I Vega-Naredo; R Loureiro; K A Mesquita; I A Barbosa; L C Tavares; A F Branco; J R Erickson; J Holy; E L Perkins; R A Carvalho; P J Oliveira
Journal:  Cell Death Differ       Date:  2014-05-16       Impact factor: 15.828

Review 8.  Revisiting Mitochondrial Function and Metabolism in Pluripotent Stem Cells: Where Do We Stand in Neurological Diseases?

Authors:  Carla Lopes; A Cristina Rego
Journal:  Mol Neurobiol       Date:  2016-02-18       Impact factor: 5.590

9.  Assisted reproductive technologies to prevent human mitochondrial disease transmission.

Authors:  Andy Greenfield; Peter Braude; Frances Flinter; Robin Lovell-Badge; Caroline Ogilvie; Anthony C F Perry
Journal:  Nat Biotechnol       Date:  2017-11-09       Impact factor: 54.908

10.  The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine.

Authors:  Jean-Pierre Etchegaray; Lukas Chavez; Yun Huang; Kenneth N Ross; Jiho Choi; Barbara Martinez-Pastor; Ryan M Walsh; Cesar A Sommer; Matthias Lienhard; Adrianne Gladden; Sita Kugel; Dafne M Silberman; Sridhar Ramaswamy; Gustavo Mostoslavsky; Konrad Hochedlinger; Alon Goren; Anjana Rao; Raul Mostoslavsky
Journal:  Nat Cell Biol       Date:  2015-04-27       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.